InsidersTradesSigma
Genocea Biosciences, INC.: insider trades · United States · SEC (Form 4)
SEC:genocea-biosciences-inc-7c7c99US·SEC (Form 4)Mcap 0M€Healthcare
Discover the full management transaction log of Genocea Biosciences, INC., a publicly traded company based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). Operating in the Healthcare sector, Genocea Biosciences, INC. has logged 30 reports. Market capitalisation: €587. The latest transaction was filed on 3 June 2022 (Cession). Among the most active insiders: Duvall Diantha. All data is free.
30
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
€3m
23 ops.
Sell Volume
Financial data
FY ended December 2021 · cache
Analyst consensus
Income statement
Revenue1.6 M€
Net income−33.2 M€-2022.9% margin
Valuation
P/Book0.0x
Beta38.32
Balance sheet & cash
Market cap587 €
Total debt17.2 M€
Free Cash Flow−48.7 M€
Debt / Equity125%
Profitability & ownership
ROE-525.8%
ROA-57.6%
% insiders0.0%
% institutions0.0%
Last declaration on 3 June 2022
Declarations0 total
No declarations found
0 of 0 declarations
About Genocea Biosciences, INC.
GENOCEA BIOSCIENCES, INC. is a biotechnology company focused on developing immunotherapies for infectious diseases and cancer. The company utilizes its vaccine discovery platform to identify unique immune targets.